SCHEMBL20219598

SCHEMBL20219598

Cc1nc(N)ncc1OCc1cn2ccccc2n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.52
▸ RAB9A P51151 7/20 0.52
▸ SMN1; SMN2 Q16637 7/20 0.52
▸ KDM4E B2RXH2 6/20 0.52
▸ TSHR P16473 1/20 0.50
▸ ALDH1A1 P00352 4/20 0.49
▸ LMNA P02545 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ PDE10A Q9Y233 3/20 0.45
▸ TP53 P04637 3/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ SIRT5 Q9NXA8 1/20 0.44
▸ HRH4 Q9H3N8 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ MAPK10 P53779 1/20 0.41
▸ HPGD P15428 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19274158 0.88 SMN1; SMN2 (0.54) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL20386792 0.83 NPC1 (0.52) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL13195702 0.80 TLR7 (0.60) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL23472701 0.78 NPC1 (0.52) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL15470285 0.78 TLR7 (0.44) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL19274250 0.78 SMN1; SMN2 (0.43) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL15470282 0.78 TLR7 (0.44) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL20219666 0.78 TLR7 (0.44) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL20219591 0.77 NPC1 (0.53) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL19274232 0.77 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330257-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS Janssen Sciences Ireland UC (IE) 2018-06-06 — — EP disclosed
Send feedback